Search for:

Biktarvy, the booming blockbuster, drives HIV market

From gene therapies and vaccines, to combination therapies and antibodies, treatments in the Cortellis Drugs to Watch 2018 report were varied both in action and target. The  Cortellis team featured 12 potential blockbusters last year which had forecasted sales of more than $1 billion by 2022.  One treatment stood out, due to its achievement of […]

World IP Day: Celebrating success

Rob Davey, VP Strategy, Intellectual Property Group, Clarivate, discusses the evolution of IP and what it is like to work for a leading IP company like Clarivate this World Intellectual Property Day   Rob Davey leads IP strategy at Clarivate, heading up a team of experts and thought leaders from across the organization’s IP brands. […]

Working at Clarivate: Life as Product Director for Cortellis, a Clarivate Analytics solution

Ketan Patel discusses his role as Product Director, the impact of technology and what the future of pharmaceutical data looks like. Ketan joined Clarivate eight months ago to head up the Clinical, Regulatory and Competitive Intelligence product development team for Cortellis, a Clarivate Analytics solution. He has fifteen years of experience in the pharmaceutical industry […]

Web of Science Group выпустила отчет Journal Citation Reports за 2019 г.

В отчете Journal Citation Reports представлены данные о цитировании значимых журналов научным сообществом благодаря широкой выборке объективных данных, метрик и аналитики по самым авторитетным академическим журналам мира, включенных в индексы Science Citation Index Expanded (SCIE) и Social Sciences Citation Index (SSCI), входящих в Web of Science Core Collection. JCR — это единственный отчет, который содержит […]

Pledging our commitment to diversity and inclusion

Clarivate signs the CEO Action for Diversity & Inclusion™, the largest CEO-driven business commitment to advance diversity and inclusion in the workplace. Today we celebrate World Day for Cultural Diversity – a day that acknowledges the value of diversity – a source of identity, innovation and creativity for all. At Clarivate, we embrace an unwavering commitment […]

Q&A: グローバル化を見据えた規制遵守のための5つのシンプルな戦略

医薬品開発および関連規制の専門家、Lawrence Libertiが、多様な市場における規制要件の複雑さと多様性に取り組むためのヒントをご紹介します。 原文サイトはこちらから (リンク先からeブックのダウンロードも可能です)   While expansion into new markets potentially introduces tremendous opportunities to scale your business, globalizing your development program doesn’t come without risks. Whether you’re a pharma or biotech from an established region looking to expand into an emerging market, or you’re looking to expand from a smaller, emerging region into a […]

Cortellisレポート: 2019年第2四半期のM&A取引総額は7%減の1,053億ドル

ELISABET CRUCES, PHARMACEUTICAL INDUSTRY ANALYST Cortellis Deals Intelligence : 2019年第2四半期のグローバルでのバイオ医薬品に関するM&A取引の実態調査   In early 2019, we released an in-depth analysis of 2018 deals activity. Here, we examine more recent activities and discuss mergers and acquisitions in the second quarter of 2019.   More deals, but lower total value Total disclosed biopharma mergers and acquisitions (M&A) value […]

A message from our CEO, Jerre Stead, about COVID-19 - Read more.